Roche Gets FDA Priority Review for Cancer Treatment
Pfenex shares rise on collaboration deal with Hospira
EUROPE MARKETS: Greek Jitters, Chinese Data Knock European Stocks Sharply Lower
UPDATE: Greek jitters, Chinese data knock European stocks sharply lower
Roche Gets U.S. Fast-Track Approval for Cancer Treatment
Roche Sees Promise in New Lymphoma Drug Study
Correction to Roche Story (2/2/15)
While a majority of our top fund managers are outperforming this year, three of them truly stand out from the rest given their ability to outperform the market over all time periods.
This fund's comeback from the financial crisis has been balky, but it still has promise.